Lectenz Bio receives patent issuance from USPTO

Date: April 10, 2018

Author: lectenz® Bio

To investigate the differences between reagents used to analyze N-glycans, we benchmarked our N-GlyFind™ Core-Specific Reagent against three commonly used lectins using the same 32 N-glycan array from Gao et al. (2019), allowing for a direct comparison of structural recognition across the four carbohydrate-binding proteins.

The Lectenz Bio team is excited to announce the approval of its patent for the Lectenz® platform technology.

This paves the way for more research and development for both Lectenz® and GlycoSense™ products.

More about the patent:

Glycan-Specific Analytical Tools. U.S. Patent Number 9,926,612 B2. This patent is for core aspects and embodiments of the Lectenz® development platform. (Patent issued by USPTO March 27, 2018.)